Wyeth looks for European boost from Enbrel NICE guidance
July 27, 2006Sales and Marketing
Wyeth's Enbrel has received a dual recommendation from NICE – guidance the pharma company hopes will influence healthcare decisions elsewhere …
Nexavar gets EU go-ahead in advanced kidney cancer
July 27, 2006Sales and Marketing
Bayer has received the green light from European regulators for Nexavar to treat the most common type of kidney cancer …
NICE boost for Taxotere
July 27, 2006Sanofi-Aventis breast cancer treatment Taxotere has been recommended by NICE in early breast cancer, giving it a boost over a …
NICE Herceptin appeal decision expected in weeks
July 27, 2006A final decision from NICE on Roche's breast cancer treatment Herceptin is expected within five weeks, following a PCT appeal …
Significant reduction in animal extremist attacks
July 27, 2006The number of attacks by animal rights extremists in the first six months of 2006 dropped sharply, building on improvements …
Aurora to raise European allergy awareness for UCB Pharma
July 26, 2006Medical Communications
Healthcare communications agency Aurora has won a pan-European account to promote UCB Pharma's non-sedating prescription antihistamine Xyzal.The agency, based in …
Tighter safeguards proposed for high-risk clinical trials
July 26, 2006Research and Development
The expert group set up by the MHRA in the wake of the disastrous Northwick Park clinical trial has made …
Novartis speeds up Tasigna programme
July 25, 2006Sales and Marketing
Novartis' new cancer drug will be submitted earlier than expected for European and US approval after showing positive results in …
Are you ready to become an interim manager?
July 25, 2006Business Services interim management, recruitment
The last few years have seen both dramatic and rapid changes in the adoption of interim management in the life …
Use your intelligence to watch the competition
July 25, 2006Research and Development, Sales and Marketing market research
One of the reasons the executives of ill-fated US energy group Enron were for a while 'the smartest guys in …
NHS allergy services criticised
July 21, 2006People with allergies often feel let down by NHS services with patient groups expected to make up shortfalls, according to …
Roche surges on cancer drug sales
July 21, 2006Sales and Marketing
Strong demand for Roche's cancer portfolio helped the Swiss pharma company grow at more than three times the industry rate …
Patient dies after winning access to cancer drug
July 21, 2006A Lancashire man with terminal lung cancer has died just days after winning a court battle to force his PCT …
Pfizer sets out on $17 billion acquisition trail
July 21, 2006Sales and Marketing Pfizer
Pfizer, the world's biggest pharmaceutical company, has earmarked $17 billion to spend on new products and technologies over the next …
UK uptake of vaccine boosts Wyeth
July 21, 2006Sales and Marketing
The long-awaited addition of Wyeth Prevnar to the UK's vaccination programme has helped the company increase revenues in the second …
Xeloda filed for advanced stomach cancer
July 21, 2006Sales and Marketing
Roche has filed its drug Xeloda to treat patients with advanced stomach cancer, the second biggest cancer killer worldwide.The oral …
New licence allows patients to switch to Arimidex
July 14, 2006Sales and Marketing
AstraZeneca has gained a new licence for its breast cancer drug Arimidex to allow patients to switch from tamoxifen after …
Tysabri returns with new safety precautions
July 13, 2006Sales and Marketing
Multiple sclerosis drug Tysabri is set to be re-launched after overcoming serious concerns about its safety.Co-marketed by Elan and Biogen …
AstraZeneca and Abbott to develop combined lipid-targeting drug
July 13, 2006Sales and Marketing
AstraZeneca and Abbott are to co-develop and market a combination treatment that will target three important blood lipids in one …
PCT fights Herceptin approval
July 12, 2006A primary care trust has appealed against the NICE recommendation of Herceptin, apparently challenging how many women should receive the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
